A Dose Confirmation Study of Oral Clofarabine for Adult Patients Previously Treated for Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Myelodysplastic Syndromes
Related studies linked through entity extraction aliases.
Chemotherapy and a Donor Natural Killer Cell Infusion in Treating Patients With Relapsed or Persistent Leukemia or Myelodysplastic Syndrome After a Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE2
Study to Assess the Safety of Escalating Doses of AT9283, in Patients With Leukemias
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Donor Stem Cell Transplant After Conditioning Therapy in Treating Patients With Hematologic Cancer, Recurrent or Metastatic Solid Tumor, or Other Disease
- Status
- COMPLETED
- Phase
- NA
Sorafenib and Low Dose Cytarabine in Older Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome
- Status
- UNKNOWN
- Phase
- PHASE2
Rasburicase in Preventing Graft-Versus-Host Disease in Patients With Hematologic Cancer or Other Disease Undergoing Donor Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib in Myelodysplastic Syndrome
- Status
- TERMINATED
- Phase
- PHASE2
Clofarabine, Cytarabine, and G-CSF in Treating Patients With Myelodysplastic Syndromes
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Aprepitant or Ondansetron in Treating Nausea and Vomiting Caused By Opioids in Patients With Cancer
- Status
- WITHDRAWN
- Phase
- NA
Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment
- Status
- COMPLETED
- Phase
- N/A
Phase I Study of Gimatecan in Patients With Myelodysplastic Syndromes
- Status
- COMPLETED
- Phase
- PHASE1
Phase IIa Vorinostat (MK0683, Suberoylanilide Hydroxamic Acid (SAHA)) Study in Lower Risk Myelodysplastic Syndromes (0683-064)
- Status
- TERMINATED
- Phase
- PHASE2
AVIDA The Vidaza® (Azacitidine) Patient Registry
- Status
- COMPLETED
- Phase
- N/A
Efficacy and Safety of Deferasirox in Patients With Myelodysplastic Syndrome and Transfusion-dependent Iron Overload
- Status
- COMPLETED
- Phase
- PHASE4
Oxaliplatin, Fludarabine, and Cytarabine in Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndromes (MDS)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Phase I Trial of Vorinostat (MK-0683, SAHA) in Combination With Decitabine in Patients With AML or MDS (MK-0683-055 EXT1)
- Status
- COMPLETED
- Phase
- PHASE1
Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)
- Status
- COMPLETED
- Phase
- NA
Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative Therapy
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3